These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19505004)

  • 1. [Tumor and angiogenesis].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2008; 125(3):487-96; discussion 497-9. PubMed ID: 19505004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical prognostic significance of tumour angiogenesis.
    Craft PS; Harris AL
    Ann Oncol; 1994 Apr; 5(4):305-11. PubMed ID: 7521203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of tumor angiogenesis as a cancer treatment].
    Verheul HM; Bom JB; Hoekman K; Pinedo HM
    Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1549-55. PubMed ID: 10443279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are tumours angiogenesis-dependent?
    Verheul HM; Voest EE; Schlingemann RO
    J Pathol; 2004 Jan; 202(1):5-13. PubMed ID: 14694516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
    Wong ML; Prawira A; Kaye AH; Hovens CM
    J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours.
    Zaffryar-Eilot S; Marshall D; Voloshin T; Bar-Zion A; Spangler R; Kessler O; Ghermazien H; Brekhman V; Suss-Toby E; Adam D; Shaked Y; Smith V; Neufeld G
    Carcinogenesis; 2013 Oct; 34(10):2370-9. PubMed ID: 23828904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour angiogenesis: the relevance to surgeons.
    Atkin GK; Chopada A
    Ann R Coll Surg Engl; 2006 Oct; 88(6):525-9. PubMed ID: 17059709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hematopoietic lineage cells as accessory components in blood vessel formation.
    Takakura N
    Cancer Sci; 2006 Jul; 97(7):568-74. PubMed ID: 16827795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Markers of angiogenesis in tumor growth].
    Nefedova NA; Kharlova OA; Danilova NV; Malkov PG; Gaifullin NM
    Arkh Patol; 2016; 78(2):55-63. PubMed ID: 27340718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coupled modelling of tumour angiogenesis, tumour growth and blood perfusion.
    Cai Y; Xu S; Wu J; Long Q
    J Theor Biol; 2011 Jun; 279(1):90-101. PubMed ID: 21392511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumour agents targeting angiogenesis.
    Drevs J; Schneider V
    J Intern Med; 2006 Dec; 260(6):517-29. PubMed ID: 17116002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of the vascular component in growth of solid tumors: a historical review].
    Ribatti D; Vacca A
    Ann Ital Med Int; 1994; 9(2):92-5. PubMed ID: 7522501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rationale and future potential of angiogenesis inhibitors in neoplasia.
    Gasparini G
    Drugs; 1999 Jul; 58(1):17-38. PubMed ID: 10439927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mathematical model of tumour angiogenesis: growth, regression and regrowth.
    Vilanova G; Colominas I; Gomez H
    J R Soc Interface; 2017 Jan; 14(126):. PubMed ID: 28100829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological features of vessel co-option versus sprouting angiogenesis.
    Latacz E; Caspani E; Barnhill R; Lugassy C; Verhoef C; Grünhagen D; Van Laere S; Fernández Moro C; Gerling M; Dirix M; Dirix LY; Vermeulen PB
    Angiogenesis; 2020 Feb; 23(1):43-54. PubMed ID: 31655928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of angiogenesis inhibitors in tumour treatment.
    Fayette J; Soria JC; Armand JP
    Eur J Cancer; 2005 May; 41(8):1109-16. PubMed ID: 15911233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumour angiogenesis and therapy directed at the neovasculature].
    Eikesdal HP; Dahl O; Straume O; Akslen LA
    Tidsskr Nor Laegeforen; 2004 Aug; 124(15):1919-22. PubMed ID: 15306859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria as targets in angiogenesis inhibition.
    Park D; Dilda PJ
    Mol Aspects Med; 2010 Feb; 31(1):113-31. PubMed ID: 19995570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour angiogenesis, anti-angiogenic therapy and chemotherapeutic resistance.
    Mander KA; Finnie JW
    Aust Vet J; 2018 Oct; 96(10):371-378. PubMed ID: 30255577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis and angiogenesis inhibitors in cancer.
    Giavazzi R; Taraboletti G
    Forum (Genova); 1999; 9(3):261-72. PubMed ID: 10504172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.